Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 159

Results For "VAI"

1901 News Found

Curran Biotech’s develops nano coating to combat Covid-19 variants
Healthcare | December 21, 2021

Curran Biotech’s develops nano coating to combat Covid-19 variants

The revolutionary new nano coating is easy to apply and rejects liquid-based contagions like COVID-19/SARS-CoV-2 and variants, influenzas, and rhinoviruses and is available via ready-to-use sprays or pre-treated air filters


Salesforce and Azim Premji Foundation launch VaxIT app to speed up Covid-19 vaccination
Public Health | December 21, 2021

Salesforce and Azim Premji Foundation launch VaxIT app to speed up Covid-19 vaccination

The VaxIT app, developed on the Salesforce platform for Azim Premji Foundation and its partners, captures the status of vaccinations to help individuals plan and stay updated on their progress


WHO grants EUL for Covovax
Drug Approval | December 20, 2021

WHO grants EUL for Covovax

First Emergency Use Listing granted by WHO for a protein-based Covid-19 vaccine


2022: Predictions for medical and healthcare industry
Opinion | December 20, 2021

2022: Predictions for medical and healthcare industry

2022 is going to be the year of opportunities and innovations from the medical industry in India


Astra Zeneca’s antibody combination to prevent Covid-19 neutralises Omicron variant
News | December 17, 2021

Astra Zeneca’s antibody combination to prevent Covid-19 neutralises Omicron variant

The study was performed independently by investigators at the US Food and Drug Administration (FDA), Center for Biologics Evaluation and Research


Telengana is now home to seven more medical devices companies
News | December 17, 2021

Telengana is now home to seven more medical devices companies

Since its launch, the medical devices park in Sultanpur has received overwhelming response with more than 50 companies lining up to set up their manufacturing or research and development units


New data suggests Covaxin generates robust memory to Covid-19 and variants six months after vaccination
Biotech | December 17, 2021

New data suggests Covaxin generates robust memory to Covid-19 and variants six months after vaccination

Effectiveness of Covaxin against the Omicron variant is currently being studied


Noorik Biopharma signs contract with Switzerland to develop ambrisentan to treat severe Covid-19
Biotech | December 16, 2021

Noorik Biopharma signs contract with Switzerland to develop ambrisentan to treat severe Covid-19

The primary objective of the ongoing trial is to determine whether ambrisentan can prevent the progression to respiratory failure and reduce the need for mechanical ventilation, among others


Immatics and Bristol Myers Squibb enter exclusive license for TCR Bispecific programme
Biotech | December 15, 2021

Immatics and Bristol Myers Squibb enter exclusive license for TCR Bispecific programme

Immatics to receive upfront payment of US $ 150 million and additional milestone payments of up to US $ 770 million plus tiered double-digit royalties on net product sales